{"symbol":"BMY","fiscalQuarter":"Q1-2016","reportDate":"2016-04-28","reportTime":"BMO","status":"reported","company":{"name":"Bristol-Myers Squibb Company","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BMY/earnings/Q1-2016","postBrief":{"headline":"Bristol-Myers Squibb Beats on EPS, Stock Up 2.89%","keyNumbers":[{"metric":"EPS","actual":"$0.74","expected":"N/A","surprise":"+12.63%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based solely on numerical results."},"guidanceChanges":{"summary":"No guidance data is available.","changes":[]},"whatItMeans":"Bristol-Myers Squibb's earnings report showed a positive surprise in EPS, which likely contributed to the stock's 2.89% increase. However, without revenue figures or management commentary, it's difficult to assess the overall performance and future outlook. Investors may be encouraged by the EPS beat but will need more information to gauge long-term prospects.","metaDescription":"Bristol-Myers Squibb (BMY) Q1 2016 earnings: EPS beat by 12.63%. Stock up 2.89%. Full breakdown."}}